Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/71941
Campo DC Valoridioma
dc.contributor.authorFornell-Perez, Robertoen_US
dc.contributor.authorVivas-Escalona, Valentinaen_US
dc.contributor.authorAranda-Sanchez, Joelen_US
dc.contributor.authorGonzalez-Dominguez, M. Carmenen_US
dc.contributor.authorRubio-Garcia, Janoen_US
dc.contributor.authorAlemán-Flores, Patriciaen_US
dc.contributor.authorLozano-Rodriguez, Alvaroen_US
dc.contributor.authorPorcel-de-Peralta, Gabrielaen_US
dc.contributor.authorLoro Ferrer, Juan Franciscoen_US
dc.date.accessioned2020-05-04T10:56:07Z-
dc.date.available2020-05-04T10:56:07Z-
dc.date.issued2020en_US
dc.identifier.issn0033-8362en_US
dc.identifier.otherWoS-
dc.identifier.urihttp://hdl.handle.net/10553/71941-
dc.description.abstractObjective: To assess the added value of diffusion-weighted imaging (DWI) to high-resolution T2-weighted sequences (HRT2w) in MRI detection of extramural venous infiltration (EMVI), according to the previous experience of radiologists. Methods: A cross-sectional study of a retrospective database including 1.5 T MRI records from 100 patients with biopsy-proven rectal cancer (2011-2016; 75 male/25 female, average 63 y/o), which included primary staging (54) and post-chemoradiotherapy follow-up MRIs (46). The reference standard was histology of surgical specimens. All cases were individually blindly reviewed by ten radiologists: three specialists in abdominal radiology, three specialized in different areas and four residents. In each case, the presence of EMVI was assessed twice: first, using just HRT2w; second, with DWI added to HRT2w. The results were pooled by experience, analyzing sensitivity, specificity, accuracy (area under ROC curve), likelihood ratios, predictive values and overstaging/understaging. Results Addition of DWI improved diagnostic performance by specialists radiologists, particularly post-chemoradiotherapy (accuracy 0.74-0.84; positive likelihood ratio 3.9-9.1; overstaging 16-8%), less so at primary staging (specificity 76-87.2%; overstaging 21-11%). Non-specialist radiologists also improved, but only at primary staging (accuracy 0.59-0.63). Residents showed small changes, except for notably increased sensitivity in both primary staging (35.7-43%) and post-chemoradiotherapy (41.7-58.3%) staging, at the expense of increased overstaging. Conclusions: The addition of DWI improved the diagnostic performance of EMVI by experienced radiologists, downgrading overstaging, especially in post-chemoradiotherapy follow-up. It resulted in fewer changes for inexperienced radiologists (enhanced primary staging) and residents (increased sensitivity).en_US
dc.languageengen_US
dc.relation.ispartofRadiologia Medicaen_US
dc.sourceRadiologia Medica [ISSN 0033-8362], v. 125, p. 522–530en_US
dc.subject320101 Oncologíaen_US
dc.subject320111 Radiologíaen_US
dc.subject.otherVascular Invasionen_US
dc.subject.otherPrognostic-Significanceen_US
dc.subject.otherChemotherapyen_US
dc.subject.otherMetastasisen_US
dc.subject.otherDiseaseen_US
dc.subject.otherMagnetic Resonance Imagingen_US
dc.subject.otherRectal Neoplasmsen_US
dc.subject.otherDiffusion-Weighted Imagingen_US
dc.subject.otherBlood Vesselsen_US
dc.titlePrimary and post-chemoradiotherapy MRI detection of extramural venous invasion in rectal cancer: the role of diffusion-weighted imagingen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1007/s11547-020-01137-7en_US
dc.identifier.isi000511074000004-
dc.identifier.eissn1826-6983-
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.contributor.daisngid34800023-
dc.contributor.daisngid31991154-
dc.contributor.daisngid31991734-
dc.contributor.daisngid34804087-
dc.contributor.daisngid11250725-
dc.contributor.daisngid6193922-
dc.contributor.daisngid6665551-
dc.contributor.daisngid32004636-
dc.contributor.daisngid29163246-
dc.description.numberofpages9en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Fornell-Perez, R-
dc.contributor.wosstandardWOS:Vivas-Escalona, V-
dc.contributor.wosstandardWOS:Aranda-Sanchez, J-
dc.contributor.wosstandardWOS:Gonzalez-Dominguez, MC-
dc.contributor.wosstandardWOS:Rubio-Garcia, J-
dc.contributor.wosstandardWOS:Aleman-Flores, P-
dc.contributor.wosstandardWOS:Lozano-Rodriguez, A-
dc.contributor.wosstandardWOS:Porcel-de-Peralta, G-
dc.contributor.wosstandardWOS:Loro-Ferrer, JF-
dc.date.coverdate2020en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.sjr0,581
dc.description.jcr3,469
dc.description.sjrqQ2
dc.description.jcrqQ2
dc.description.scieSCIE
item.fulltextSin texto completo-
item.grantfulltextnone-
crisitem.author.deptGIR IUIBS: Bioquímica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Clínicas-
crisitem.author.orcid0000-0002-0517-8209-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameLoro Ferrer, Juan Francisco-
Colección:Artículos
Vista resumida

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.